Dialysis Furniture Market Size, Share, and Industry Analysis, By Product Type (Dialysis Chairs, Dialysis Beds, Treatment Trolleys & Utility Furniture, and Others), By End-user (Hospital-based Dialysis Units, Standalone Dialysis Centers, Home Dialysis Settings, and Others), and Regional Forecast till 2034

The dialysis furniture market size was valued at USD 320.9 million in 2025 and is expected to reach a market valuation of USD 335.6 million in 2026. Furthermore, the market is projected to reach a valuation of USD 480.3 million by 2034, exhibiting a CAGR of 4.6% during the forecast period.

The market growth is attributed to the expansion of independent dialysis centers in emerging markets in the Asia Pacific, Latin America, and the Middle East, which is driving the requirement for multiple dialysis chairs, storage units, nurse stations, and patient waiting furniture.

Dialysis Furniture Market Driver

Rising Prevalence of Chronic Kidney Disease (CKD) to Drive the Market Growth

In recent years, there has been an increasing prevalence of chronic kidney disease and end-stage renal disease (ESRD), which is directly driving demand for dialysis infrastructure, including specialized furniture. This prevalence is expected to increase due to an increasing geriatric population, diabetes cases, hypertension, and lifestyle disorders, driving the demand for dialysis and associated furniture, contributing to market expansion.

• For instance, according to the data published by the Centers for Disease Control and Prevention in May 2024, approximately 14.0% of U.S. adults, or 35.5 million individuals, have chronic kidney disease (CKD), affecting more than 1 in 7 people.

Download Free sample to learn more about this report.

According to data published by the International Society of Nephrology (ISN), the prevalence of CKD worldwide was around 10.4% among men and 11.8% among women as of 2025.

Dialysis Furniture Market Restraint

Intense Price Competition from Regional Manufacturers to Hamper the Market Growth

In several countries, numerous regional and local manufacturers are offering low-cost alternatives. Domestic manufacturers, particularly in the Asia Pacific, are supplying affordable dialysis furniture that meets basic regulatory requirements, limiting pricing power for premium brands. Such a scenario is anticipated to hinder the market expansion.

Dialysis Furniture Market Opportunity

Rising Demand for Bariatric and Specialized Designs to Offer Lucrative Growth Opportunity

In recent years, obesity prevalence has been increasing worldwide, which is creating demand for bariatric-capacity dialysis chairs with higher weight limits and reinforced structural design. As a result, facilities are investing in specialized designs to ensure patient safety and regulatory compliance. This is expected to offer significant opportunities for key players to introduce bariatric dialysis chairs with enhanced load-bearing capacity.

• For instance, according to the World Heart Federation in February 2026, nearly 2.3 billion children and adults worldwide are affected by overweight and obesity.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence/Incidence of Key Conditions, by Countries/Region, 2025
• Technological Advancements in Dialysis Furniture
• Key Industry Developments - (Partnerships, Mergers, and Acquisitions, etc.)

Analysis by Product Type

By product type, the market is segmented into dialysis chairs, dialysis beds, treatment trolleys & utility furniture, and others.

The dialysis chairs segment is expected to hold the major share of the global market during the forecast period. Dialysis chairs are more widely used as most outpatient dialysis treatments are performed in a seated position, with sessions lasting 3-5 hours, typically three times per week, making seating a clinical necessity. This is expected to drive the segment’s growth.

Analysis by End-user

Based on end-user, the market is divided into hospital-based dialysis units, standalone dialysis centers, home dialysis settings, and others.

The hospital-based dialysis units segment is expected to hold the largest share of the global market during the forecast period. Dialysis services are predominantly delivered through public and government hospitals in several countries, driving demand for dialysis chairs, beds, and treatment furniture. Moreover, a significant number of hospitals in developed countries are also expected to contribute to this demand, driving the segment’s growth.

• For instance, according to 2026 American Hospital Association (AHA) data, there are approximately 6,100 hospitals in the U.S.

Regional Analysis

Request for Customization   to gain extensive market insights.

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for a 30.9% share of the global dialysis furniture market in 2025. The growth is attributed to an expansion of dialysis centers, which is expected to favor the adoption of dialysis furniture in the region.

• For instance, in December 2025, Citizens Memorial Hospital (CMH) held a ribbon-cutting ceremony for its new 10,488-square-foot Dialysis Center, attended by over 250 people and featuring 16 hemodialysis chairs and advanced technology.

Asia Pacific is expected to grow at the highest CAGR during the forecast period. The region’s growth is attributed to expanding healthcare infrastructure, which is attracting key players to enter emerging markets such as India, China, South Korea, and others.

Key Players Covered

The global dialysis furniture market is highly fragmented, with key players partnering and signing distribution agreements to expand into the worldwide market.

The report includes the profiles of the following key players:

• Digiterm Ltd. (Hungary)
• Diasol, Inc. (U.S.)
• SAIKANG MEDICAL (China)
• MC Dons Medical Group (India)
• Lemi MD (Italy)
• Champion Manufacturing Inc. (U.S.)
• Favero Health Projects (Italy)
• Bionic Medizintechnik (Germany)
• BiHealthcare (China)
• Baseline Bio-Medical Company (U.S.)

Key Industry Developments

• June 2025: Fresenius Medical Care AG began broader U.S. commercialization of its 5008X CAREsystem after receiving FDA 510(k) clearance for an updated version with added features, including the Clinical Data Exchange (CDX).
• June 2025: Outset Medical's next-generation Tablo Hemodialysis System received FDA 510(k) clearance, becoming the first dialysis system to meet the agency's most rigorous cybersecurity standards.